0.85Open1.80Pre Close61 Volume63 Open Interest17.50Strike Price4.33KTurnover7479.80%IV4.53%PremiumDec 20, 2024Expiry Date0.37Intrinsic Value100Multiplier-2DDays to Expiry0.81Extrinsic Value100Contract SizeAmericanOptions Type0.5673Delta0.1482Gamma15.14Leverage Ratio-367.1899Theta0.0000Rho8.59Eff Leverage0.0001Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet